Dynamics of antigen presentation to transgene product-specific CD4+ T cells and of Treg induction upon hepatic AAV gene transfer

Molecular Therapy Methods and Clinical Development

Volumn 3, Issue , 2016, Pages 16083-

  Perrin, George Q ^a   Zolotukhin, Irene ^a   Sherman, Alexandra ^a   Biswas, Moanaro ^a   de Jong, Ype P ^b   Terhorst, Cox ^c   Davidoff, Andrew M ^d   Herzog, Roland W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DYNAMICS; GENE TRANSFER; IN VIVO STUDY; LIVER; LYMPH NODE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC CIRCULATION; TRANSGENE; VIRUS GENE; CYTOPLASM; LYMPHOCYTE PROLIFERATION;

EID: 85015254488     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2016.83     Document Type: Article

References (51)

1. 1 Hoffman, BE, Herzog, RW, Immunology of hepatic gene transfer. Herzog, RW, (eds.) Gene Therapy Immunology, 2009, Wiley-Blackwell, Hoboken, NJ, 143–166.
2. 2 Heymann, F, Tacke, F, Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol 13 (2016), 88–110.
3. 3 LoDuca, PA, Hoffman, BE, Herzog, RW, Hepatic gene transfer as a means of tolerance induction to transgene products. Curr Gene Ther 9 (2009), 104–114.
4. 4 Sack, BK, Herzog, RW, Terhorst, C, Markusic, DM, Development of gene transfer for induction of antigen-specific tolerance. Mol Ther Methods Clin Dev, 1, 2014, 14013.
5. 5 Annoni, A, Brown, BD, Cantore, A, Sergi, LS, Naldini, L, Roncarolo, MG, In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance. Blood 114 (2009), 5152–5161.
6. 6 Mátrai, J, Cantore, A, Bartholomae, CC, Annoni, A, Wang, W, Acosta-Sanchez, A, et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 53 (2011), 1696–1707.
7. 7 Cao, O, Dobrzynski, E, Wang, L, Nayak, S, Mingle, B, Terhorst, C, et al. Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 110 (2007), 1132–1140.
8. 8 Dobrzynski, E, Mingozzi, F, Liu, YL, Bendo, E, Cao, O, Wang, L, et al. Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. Blood 104 (2004), 969–977.
9. 9 Hoffman, BE, Dobrzynski, E, Wang, L, Hirao, L, Mingozzi, F, Cao, O, et al. Muscle as a target for supplementary factor IX gene transfer. Hum Gene Ther 18 (2007), 603–613.
10. 10 Markusic, DM, Hoffman, BE, Perrin, GQ, Nayak, S, Wang, X, LoDuca, PA, et al. Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies. EMBO Mol Med 5 (2013), 1698–1709.
11. 11 Mingozzi, F, Liu, YL, Dobrzynski, E, Kaufhold, A, Liu, JH, Wang, Y, et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 111 (2003), 1347–1356.
12. 12 Dobrzynski, E, Fitzgerald, JC, Cao, O, Mingozzi, F, Wang, L, Herzog, RW, Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. Proc Natl Acad Sci USA 103 (2006), 4592–4597.
13. 13 Akbarpour, M, Goudy, KS, Cantore, A, Russo, F, Sanvito, F, Naldini, L, et al. Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs. Sci Transl Med, 7, 2015, 289ra81.
14. 14 Kumar, SR, Markusic, DM, Biswas, M, High, KA, Herzog, RW, Clinical development of gene therapy: results and lessons from recent successes. Mol Ther Methods Clin Dev, 3, 2016, 16034.
15. 15 Chan, CC, Lai, CW, Wu, CJ, Chen, LC, Tao, MH, Kuo, ML, Liver-specific allergen gene transfer by adeno-associated virus suppresses allergic airway inflammation in mice. Hum Gene Ther 27 (2016), 631–642.
16. 16 Annoni, A, Cantore, A, Della Valle, P, Goudy, K, Akbarpour, M, Russo, F, et al. Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice. EMBO Mol Med 5 (2013), 1684–1697.
17. 17 Crudele, JM, Finn, JD, Siner, JI, Martin, NB, Niemeyer, GP, Zhou, S, et al. AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice. Blood 125 (2015), 1553–1561.
18. 18 Finn, JD, Ozelo, MC, Sabatino, DE, Franck, HW, Merricks, EP, Crudele, JM, et al. Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy. Blood 116 (2010), 5842–5848.
19. 19 Doerfler, PA, Todd, AG, Clément, N, Falk, DJ, Nayak, S, Herzog, RW, et al. Copackaged AAV9 vectors promote simultaneous immune tolerance and phenotypic correction of Pompe disease. Hum Gene Ther 27 (2016), 43–59.
20. 20 Wang, G, Young, SP, Bali, D, Hutt, J, Li, S, Benson, J, et al. Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease. Mol Ther Methods Clin Dev, 1, 2014, 14018.
21. 21 Zhang, P, Sun, B, Osada, T, Rodriguiz, R, Yang, XY, Luo, X, et al. Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease. Hum Gene Ther 23 (2012), 460–472.
22. 22 Hoffman, BE, Martino, AT, Sack, BK, Cao, O, Liao, G, Terhorst, C, et al. Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer. Mol Ther 19 (2011), 1263–1272.
23. 23 Liao, G, Nayak, S, Regueiro, JR, Berger, SB, Detre, C, Romero, X, et al. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int Immunol 22 (2010), 259–270.
24. 24 Liao, G, O'Keeffe, MS, Wang, G, van Driel, B, de Waal Malefyt, R, Reinecker, HC, et al. Glucocorticoid-induced TNF receptor family-related protein ligand is requisite for optimal functioning of regulatory CD4(+) T cells. Front Immunol, 5, 2014, 35.
25. 25 Breous, E, Somanathan, S, Vandenberghe, LH, Wilson, JM, Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology 50 (2009), 612–621.
26. 26 Faust, SM, Bell, P, Zhu, Y, Sanmiguel, J, Wilson, JM, The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer. Mol Ther 21 (2013), 2227–2235.
27. 27 Carambia, A, Freund, B, Schwinge, D, Heine, M, Laschtowitz, A, Huber, S, et al. TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells. J Hepatol 61 (2014), 594–599.
28. 28 Cooper, M, Nayak, S, Hoffman, BE, Terhorst, C, Cao, O, Herzog, RW, Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer. Hum Gene Ther 20 (2009), 767–776.
29. 29 Vercauteren, K, Hoffman, BE, Zolotukhin, I, Keeler, GD, Xiao, JW, Basner-Tschakarjan, E, et al. Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid. Mol Ther 24 (2016), 1042–1049.
30. 30 Laskin, DL, Sunil, VR, Gardner, CR, Laskin, JD, Macrophages and tissue injury: agents of defense or destruction?. Annu Rev Pharmacol Toxicol 51 (2011), 267–288.
31. 31 Wang, L, Dobrzynski, E, Schlachterman, A, Cao, O, Herzog, RW, Systemic protein delivery by muscle-gene transfer is limited by a local immune response. Blood 105 (2005), 4226–4234.
32. 32 Barbier, L, Tay, SS, McGuffog, C, Triccas, JA, McCaughan, GW, Bowen, DG, et al. Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. J Hepatol 57 (2012), 352–358.
33. 33 Zheng, M, Yu, J, Tian, Z, Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV. Cell Mol Immunol 10 (2013), 143–150.
34. 34 Vendrell, A, Mongini, C, Gravisaco, MJ, Canellada, A, Tesone, AI, Goin, JC, et al. An oral salmonella-based vaccine inhibits liver metastases by promoting tumor-specific T-cell-mediated immunity in celiac and portal lymph nodes: a preclinical study. Front Immunol, 7, 2016, 72.
35. 35 Biswas, M, Sarkar, D, Kumar, SR, Nayak, S, Rogers, GL, Markusic, DM, et al. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg. Blood 125 (2015), 2937–2947.
36. 36 Cao, O, Hoffman, BE, Moghimi, B, Nayak, S, Cooper, M, Zhou, S, et al. Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B. Mol Ther 17 (2009), 1733–1742.
37. 37 Sarkar, D, Biswas, M, Liao, G, Seay, HR, Perrin, GQ, Markusic, DM, et al. Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia. Mol Ther Methods Clin Dev, 1, 2014, 14030.
38. 38 Brinkmann, V, Davis, MD, Heise, CE, Albert, R, Cottens, S, Hof, R, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277 (2002), 21453–21457.
39. 39 Matloubian, M, Lo, CG, Cinamon, G, Lesneski, MJ, Xu, Y, Brinkmann, V, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004), 355–360.
40. 40 Brinkmann, V, Pinschewer, DD, Feng, L, Chen, S, FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 72 (2001), 764–769.
41. 41 Horst, AK, Neumann, K, Diehl, L, Tiegs, G, Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol 13 (2016), 277–292.
42. 42 Lippens, C, Duraes, FV, Dubrot, J, Brighouse, D, Lacroix, M, Irla, M, et al. IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity. J Autoimmun, 2016 (epub ahead of print).
43. 43 Martino, AT, Herzog, RW, Anegon, I, Adjali, O, Measuring immune responses to recombinant AAV gene transfer. Methods Mol Biol 807 (2011), 259–272.
44. 44 Somanathan, S, Breous, E, Bell, P, Wilson, JM, AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells. Mol Ther 18 (2010), 977–982.
45. 45 Rogers, GL, Martino, AT, Aslanidi, GV, Jayandharan, GR, Srivastava, A, Herzog, RW, Innate immune responses to AAV vectors. Front Microbiol, 2, 2011, 194.
46. 46 Hoffman, BE, Herzog, RW, Coaxing the liver into preventing autoimmune disease in the brain. J Clin Invest 118 (2008), 3271–3273.
47. 47 Lüth, S, Huber, S, Schramm, C, Buch, T, Zander, S, Stadelmann, C, et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 118 (2008), 3403–3410.
48. 48 Martino, AT, Nayak, S, Hoffman, BE, Cooper, M, Liao, G, Markusic, DM, et al. Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity. PLoS One, 4, 2009, e6376.
49. 49 Passini, MA, Bu, J, Fidler, JA, Ziegler, RJ, Foley, JW, Dodge, JC, et al. Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse. Proc Natl Acad Sci USA 104 (2007), 9505–9510.
50. 50 Hultkrantz, S, Ostman, S, Telemo, E, Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology 116 (2005), 362–372.
51. 51 Nietupski, JB, Hurlbut, GD, Ziegler, RJ, Chu, Q, Hodges, BL, Ashe, KM, et al. Systemic administration of AAV8-α-galactosidase A induces humoral tolerance in nonhuman primates despite low hepatic expression. Mol Ther 19 (2011), 1999–2011.